Uro-458 (Method Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the Uro-458 drug offered from Method Pharmaceuticals, LLC. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Method Pharmaceuticals, LLC |
| NON-PROPRIETARY NAME: | Methenamine, Sodium Phosphate, Monobasic, Anhydrous, Phenyl Salicylate, Methylene Blue and Hyoscyamine Sulfate |
| SUBSTANCE NAME: | METHENAMINE; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS; PHENYL SALICYLATE; METHYLENE BLUE; HYOSCYAMINE SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2016-06-17 |
| END MARKETING DATE: | 0000-00-00 |
Uro-458 HUMAN PRESCRIPTION DRUG Details:
| Item Description | Uro-458 from Method Pharmaceuticals, LLC |
| LABELER NAME: | Method Pharmaceuticals, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 81; 40.8; 32.4; 10.8; .12(mg/1; mg/1; mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2016-06-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 58657-458_37229472-72d0-07ee-e054-00144ff88e88 |
| PRODUCT NDC: | 58657-458 |
| APPLICATION NUMBER: | |
Other METHENAMINE; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS; PHENYL SALICYLATE; METHYLENE BLUE; HYOSCYAMINE SULFATE Pharmaceutical Manufacturers / Labelers:
